JP2016532713A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016532713A5 JP2016532713A5 JP2016540378A JP2016540378A JP2016532713A5 JP 2016532713 A5 JP2016532713 A5 JP 2016532713A5 JP 2016540378 A JP2016540378 A JP 2016540378A JP 2016540378 A JP2016540378 A JP 2016540378A JP 2016532713 A5 JP2016532713 A5 JP 2016532713A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- hydrogen
- independently
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 36
- 239000001257 hydrogen Substances 0.000 claims 36
- 125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 claims 22
- 150000003839 salts Chemical class 0.000 claims 22
- 150000001875 compounds Chemical class 0.000 claims 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 18
- 150000002431 hydrogen Chemical class 0.000 claims 18
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 17
- 125000001072 heteroaryl group Chemical group 0.000 claims 17
- 229910052736 halogen Inorganic materials 0.000 claims 13
- 150000002367 halogens Chemical class 0.000 claims 13
- 125000003118 aryl group Chemical group 0.000 claims 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 11
- -1 —C 1 -C 6 alkyl-aryl Chemical group 0.000 claims 11
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 8
- 125000003107 substituted aryl group Chemical group 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 2
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 230000005856 abnormality Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 241001303601 Rosacea Species 0.000 claims 1
- 208000006981 Skin Abnormalities Diseases 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000005349 heteroarylcycloalkyl group Chemical group 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 230000037390 scarring Effects 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361873746P | 2013-09-04 | 2013-09-04 | |
| US61/873,746 | 2013-09-04 | ||
| PCT/US2014/054065 WO2015035027A1 (en) | 2013-09-04 | 2014-09-04 | Liver x receptor (lxr) modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016532713A JP2016532713A (ja) | 2016-10-20 |
| JP2016532713A5 true JP2016532713A5 (enExample) | 2017-10-12 |
Family
ID=52628920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540378A Pending JP2016532713A (ja) | 2013-09-04 | 2014-09-04 | 肝臓ｘ受容体（ｌｘｒ）調節因子 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9981913B2 (enExample) |
| EP (1) | EP3041834A4 (enExample) |
| JP (1) | JP2016532713A (enExample) |
| KR (1) | KR20160048997A (enExample) |
| CN (1) | CN105683176A (enExample) |
| CA (1) | CA2923178A1 (enExample) |
| IL (1) | IL244412A0 (enExample) |
| MX (1) | MX2016002930A (enExample) |
| SG (1) | SG11201601644RA (enExample) |
| WO (1) | WO2015035027A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3441390A1 (en) | 2012-03-02 | 2019-02-13 | Ralexar Therapeutics, Inc. | Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions |
| AU2014315280B2 (en) | 2013-09-04 | 2019-01-24 | Ellora Therapeutics, Inc. | Liver X receptor (LXR) modulators |
| EP3124620B1 (en) * | 2015-07-27 | 2018-08-08 | Chanel Parfums Beauté | Activators of uc.291 for use for improving skin barrier function and/or for preventing and/or attenuating skin ageing and/or for hydrating skin |
| CN111100071A (zh) * | 2019-12-19 | 2020-05-05 | 西安近代化学研究所 | 一种合成2-氰基-5-芳基-1h-咪唑类化合物的方法 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040072868A1 (en) | 2000-09-18 | 2004-04-15 | Collins Jon Loren | Substitued aminopropoxyaryl derivatives useful as agonists for lxr |
| AUPR738301A0 (en) | 2001-08-30 | 2001-09-20 | Starpharma Limited | Chemotherapeutic agents |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| CA2486651A1 (en) | 2002-05-24 | 2003-12-04 | Pharmacia Corporation | Sulfone liver x-receptor modulators |
| US6900244B2 (en) | 2002-05-24 | 2005-05-31 | Pharmacia Corporation | Anilino liver X-receptor modulators |
| EP1572660B1 (en) | 2002-12-20 | 2011-01-26 | X-Ceptor Therapeutics, Inc. | Isoquinolinone derivatives and their use as therapeutic agents |
| US20060270628A1 (en) * | 2003-04-29 | 2006-11-30 | Jagattaran Das | Antiinfective 1,2,3-triazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| JP2006193426A (ja) | 2003-09-05 | 2006-07-27 | Sankyo Co Ltd | 置換された縮環ピリミジン−４（３ｈ）−オン化合物 |
| WO2005113499A1 (ja) | 2004-05-20 | 2005-12-01 | Sankyo Company, Limited | インドール化合物 |
| TW200606133A (en) | 2004-06-30 | 2006-02-16 | Sankyo Co | Substituted benzene compounds |
| AU2005271737A1 (en) | 2004-08-03 | 2006-02-16 | Wyeth | Indazoles useful in treating cardiovascular diseases |
| US20070060589A1 (en) | 2004-12-21 | 2007-03-15 | Purandare Ashok V | Inhibitors of protein arginine methyl transferases |
| WO2006109633A1 (ja) | 2005-04-07 | 2006-10-19 | Daiichi Sankyo Company, Limited | 置換インドール化合物 |
| US7213797B2 (en) | 2005-05-20 | 2007-05-08 | Garland Jerome Gaskins | Deck board straightener |
| CN101248049B (zh) | 2005-06-27 | 2013-08-28 | 埃克塞利希斯专利有限责任公司 | 咪唑类lxr调节剂 |
| WO2007002563A1 (en) * | 2005-06-27 | 2007-01-04 | Exelixis, Inc. | Imidazole based lxr modulators |
| AU2006290442B2 (en) | 2005-09-16 | 2010-07-29 | Arrow Therapeutics Limited | Biphenyl derivatives and their use in treating hepatitis C |
| WO2007034279A2 (en) | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | C3a antagonists and pharmaceutical compositions thereof |
| WO2007092065A2 (en) | 2005-11-14 | 2007-08-16 | Irm Llc | Compounds and compositions as lxr modulators |
| EP1849781A1 (en) | 2006-04-28 | 2007-10-31 | Laboratorios del Dr. Esteve S.A. | Substituted 3-Amino-4-hydroxy pyrrolidines compounds, their preparation and use as medicaments |
| TW200825054A (en) | 2006-10-18 | 2008-06-16 | Wyeth Corp | Quinoline compounds |
| WO2008073825A1 (en) | 2006-12-08 | 2008-06-19 | Exelixis, Inc. | Lxr and fxr modulators |
| US8338437B2 (en) | 2007-02-28 | 2012-12-25 | Methylgene Inc. | Amines as small molecule inhibitors |
| MX2009012474A (es) | 2007-05-18 | 2009-12-18 | Wyeth Corp | Compuestos de quinazolina. |
| US20090069288A1 (en) | 2007-07-16 | 2009-03-12 | Breinlinger Eric C | Novel therapeutic compounds |
| CN103772299A (zh) | 2007-08-13 | 2014-05-07 | 霍夫曼-拉罗奇有限公司 | 新型哌嗪酰胺衍生物 |
| BRPI0821315A2 (pt) | 2007-12-21 | 2019-09-24 | Wyeth Llc | compostos benzimidazol |
| BRPI0822237A2 (pt) | 2007-12-21 | 2015-06-30 | Wyeth Llc | Compostos de imidazo [1,2-a] piridina |
| US20120015988A1 (en) | 2008-05-13 | 2012-01-19 | Boehringer Ingelheim International Gmbh | Sulfone Compounds Which Modulate The CB2 Receptor |
| US8063088B2 (en) | 2008-06-11 | 2011-11-22 | Hoffmann-La Roche Inc. | Imidazolidine derivatives |
| JP2012508250A (ja) | 2008-11-07 | 2012-04-05 | ワイス・エルエルシー | キノキサリン系のｌｘｒモジュレーター |
| EP2367801A1 (en) | 2008-11-19 | 2011-09-28 | Wyeth LLC | Polar quinazolines as liver x receptors ( lxrs ) modulators |
| CA2747744A1 (en) * | 2008-12-22 | 2010-07-01 | Theodros Asberom | Gamma secretase modulators |
| US20120058133A1 (en) | 2009-02-19 | 2012-03-08 | President And Fellows Of Harvard College | Inhibition of trna synthetases and therapeutic applications thereof |
| WO2010096777A1 (en) | 2009-02-23 | 2010-08-26 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
| HRP20170194T1 (hr) | 2009-05-28 | 2017-05-19 | Exelixis Patent Company Llc | Lxr modulatori |
| GB0919757D0 (en) | 2009-11-12 | 2009-12-30 | Johnson Matthey Plc | Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| EP2501696B1 (en) | 2009-10-15 | 2016-12-28 | Guerbet | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
| WO2012019093A1 (en) | 2010-08-05 | 2012-02-09 | Human Biomolecular Research Institute | Synthetic compounds and methods to decrease nicotine self-administration |
| WO2012020820A1 (ja) | 2010-08-11 | 2012-02-16 | 大正製薬株式会社 | ヘテロアリール－ピラゾール誘導体 |
| CN103180316A (zh) | 2010-08-27 | 2013-06-26 | 钙医学公司 | 调节细胞内钙的化合物 |
| CN102584705B (zh) | 2011-01-18 | 2015-05-13 | 中国中化股份有限公司 | 3-羟基-取代吡唑的制备方法 |
| AR088728A1 (es) | 2011-03-25 | 2014-07-02 | Bristol Myers Squibb Co | Moduladores de lxr como prodroga de imidazol |
| EP3441390A1 (en) | 2012-03-02 | 2019-02-13 | Ralexar Therapeutics, Inc. | Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions |
| ES2765573T3 (es) | 2012-08-13 | 2020-06-09 | Univ Rockefeller | Tratamiento y diagnóstico de melanoma |
| AU2014315280B2 (en) | 2013-09-04 | 2019-01-24 | Ellora Therapeutics, Inc. | Liver X receptor (LXR) modulators |
-
2014
- 2014-09-04 SG SG11201601644RA patent/SG11201601644RA/en unknown
- 2014-09-04 CA CA2923178A patent/CA2923178A1/en not_active Abandoned
- 2014-09-04 JP JP2016540378A patent/JP2016532713A/ja active Pending
- 2014-09-04 KR KR1020167008710A patent/KR20160048997A/ko not_active Withdrawn
- 2014-09-04 CN CN201480058803.0A patent/CN105683176A/zh active Pending
- 2014-09-04 US US14/916,292 patent/US9981913B2/en not_active Expired - Fee Related
- 2014-09-04 MX MX2016002930A patent/MX2016002930A/es unknown
- 2014-09-04 EP EP14841483.2A patent/EP3041834A4/en not_active Withdrawn
- 2014-09-04 WO PCT/US2014/054065 patent/WO2015035027A1/en not_active Ceased
-
2016
- 2016-03-03 IL IL244412A patent/IL244412A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201891553A1 (ru) | Ингибиторы syk | |
| EA201690094A1 (ru) | Ингибиторы syk | |
| JP2015537008A5 (enExample) | ||
| CY1119727T1 (el) | Ενωσεις και συνθεσεις για τη θεραπεια παρασιτικων νοσων | |
| AR088175A1 (es) | 3-pirimidin-4-il-oxazolidin-2-onas utiles para tratar cancer y composiciones farmaceuticas que las contienen | |
| CA2918938C (en) | Substituted aminopyrimidine compounds and methods of use | |
| EA201690752A1 (ru) | Ингибиторы g12c kras | |
| MX375970B (es) | Compuestos de triazolopirimidina y usos de los mismos. | |
| UA113541C2 (xx) | Заміщені піролідин-2-карбоксаміди | |
| JP2014511891A5 (enExample) | ||
| EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
| EA201690268A1 (ru) | Замещенные производные хиназолин-4-она | |
| EA201490647A1 (ru) | Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции | |
| EA201491672A1 (ru) | Гетероциклильные соединения как ингибиторы mek | |
| EA201590581A1 (ru) | Соединения бис-(фторалкил)-1,4-бензодиазепинона и их пролекарства | |
| JP2016531126A5 (enExample) | ||
| CO6390038A2 (es) | Derivados de sulfonamida como agentes inductores de apoptosis con selectividad por bcl-2 para el tratamiento de cancer y enfermedades inmunes | |
| JP2016503797A5 (enExample) | ||
| EA201691141A1 (ru) | Соединения против ccr6 | |
| RU2017104856A (ru) | Функционализированные и замещенные индолы в качестве противораковых средств | |
| EA201892246A1 (ru) | Производные аминотиазола, полученные в качестве противовирусных средств | |
| EA201591024A1 (ru) | Димерные соединения | |
| EA201391558A1 (ru) | Тетрагидропиразоло[1,5-а]пиримидины как противотуберкулезные соединения | |
| EA201491820A1 (ru) | Новые тиенопиримидиновые производные, способы их получения и их терапевтические применения | |
| EA201600434A1 (ru) | Применение производных бензимидазолпролина |